Literature DB >> 11410812

Surgical treatment of parathyroid carcinoma (Review).

T Hoelting1, T Weber, J Werner, C Herfarth.   

Abstract

Cancer of the parathyroid gland is rare and most patients suffer from hyperparathyroidism (HPT). Therefore it is often difficult to distinguish between benign HPT and malignant disorders. Prognosis as well as therapeutic approaches are still limited. Surgical treatment should be considered the therapy of choice for primary and recurrent manifestation of parathyroid carcinoma. The initial operation includes en-bloc resection of the tumor and the ipsilateral thyroid lobe. Surgery may cure some patients, but is often only palliative and aims to control hypercalcemia. In some patients hypercalcemia may be refractory to repeated surgery and medical treatment can provide short- or middle-term effects.

Entities:  

Mesh:

Year:  2001        PMID: 11410812     DOI: 10.3892/or.8.4.931

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

Review 1.  Parathyroid cancer.

Authors:  Fiona McClenaghan; Yassar A Qureshi
Journal:  Gland Surg       Date:  2015-08

Review 2.  Best practice no 183. Examination of parathyroid gland specimens.

Authors:  S J Johnson; E A Sheffield; A M McNicol
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 3.  Parathyroid carcinoma.

Authors:  B Givi; J P Shah
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-05-26       Impact factor: 4.126

Review 4.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

5.  Huge parathyroid carcinoma: clinical considerations and literature review.

Authors:  Maria Grazia Chiofalo; Francesco Scognamiglio; Simona Losito; Secondo Lastoria; Ugo Marone; Luciano Pezzullo
Journal:  World J Surg Oncol       Date:  2005-06-23       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.